HCA Healthcare stock gains support as BofA raises price target after new dividend
Published on 09/15/2026 at 12:19 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
HCA Healthcare stock (ISIN US40412C1018) recently closed at about USD 425.50 on the New York Stock Exchange as of September 14, 2026, leaving the company with a market capitalization of roughly USD 92.1 billion. On September 14, 2026, a report from Ad-hoc news summarized that the board declared a new quarterly dividend of USD 0.78 per share, adding a fresh income component for investors.
Dividend and analyst backdrop
According to Ad-hoc news on September 14, 2026, the newly declared dividend of USD 0.78 per share reflects the latest quarterly payout, which at the recent share price translates into a cash yield in the area of 0.7 percent. The same report cites a MarketBeat overview noting that analysts maintain a moderate buy consensus on the shares, suggesting that many research houses still see upside potential from the current level.
As MarketScreener reported on September 14, 2026, Bank of America raised its price target on HCA Healthcare stock to USD 450 from USD 425 while keeping a positive view on the shares. Compared with the recent closing level around USD 425.50, the new target implies upside of roughly 5.7 percent, highlighting that BofA still expects further gains despite the stock’s strong run in recent weeks.
Valuation, fundamentals and sector positioning
Per data compiled by INDmoney as of September 14, 2026, HCA Healthcare traded at a price to earnings ratio of 14.33 times, compared with an industry multiple of 13.88 times on the same date. That means the stock carries a modest premium of about 3.2 percent to the broader healthcare provider peer group on this metric, reflecting investors’ willingness to pay slightly more for its earnings profile.
The same INDmoney overview notes that the shares stood about 23.5 percent below their 52-week high of USD 556.52 and around 20.2 percent above their 52-week low of USD 353.99 as of mid-September 2026. In practical terms, that places the current price near the middle of the 52-week corridor, indicating that the stock has already recovered significantly from its lows but still trades at a noticeable discount to its recent peak.
INDmoney also highlights that HCA Healthcare stock gained roughly 5.8 percent over the last seven days as of September 15, 2026, outpacing many broader market benchmarks over the same period. Together with the moderate buy consensus and the average analyst target price of USD 451.48, which is about 5.8 percent above the current level, this short-term performance underlines that the market is gradually repricing the company after the most recent news flow while still leaving room for further appreciation if earnings and cash flows continue to develop favorably.
Operations, investments and digital initiatives
On the operational side, HCA Healthcare announced a USD 32 million investment to upgrade several regional hospitals in western North Carolina, including Transylvania Regional Hospital. As BrevardBeagle.com reported on September 14, 2026, the package includes projects such as orthopedic program expansions and other infrastructure upgrades, signaling continued capital spending to support regional growth.
In parallel, HCA Healthcare is advancing its digitalization strategy. According to Morningstar on September 14, 2026, the MEDITECH Expanse electronic health record platform went live across the first full United States divisions of HCA Healthcare, aiming to improve data integration and clinical workflows across the network. Such initiatives typically require significant upfront spending but can enhance efficiency and quality metrics over time, a factor that many analysts consider when assessing long-term valuation.
Stock price level and trading metrics
INDmoney data show that HCA Healthcare stock closed at USD 425.49 on the NYSE on September 14, 2026, after trading in an intraday range between USD 420.00 and USD 433.80. Trading volume for that session was within a normal band and contributed to a total market capitalization of about USD 92.4 billion, while the stock’s recent price move left it 23.54 percent below the 52-week high of USD 556.52 and 20.20 percent above the 52-week low of USD 353.99 as of mid-September 2026.
Key data on HCA Healthcare stock
- Company: HCA Healthcare Inc.
- ISIN: US40412C1018
- Ticker: HCA
- Trading venue: NYSE
- Price (as of September 14, 2026): 425.49 USD
- Market capitalization: 92,400,000,000 USD (as of September 14, 2026)
- Sector / Industry: Healthcare / Hospitals
- Index membership: S amp P 500
